U.S. Tech Hardware Stock News

LyondellBasell Industries (LYB) has moved into focus after receiving a Zacks Rank #1 rating, a shift driven by higher earnings estimates, growth indicators and a dividend yield that stands out in its sector. See our latest analysis for LyondellBasell Industries. Despite the positive earnings revisions and Zacks Rank upgrade, LyondellBasell Industries has seen its share price fall 16.38% over the past month and 32.35% over the past quarter, while the 1 year total shareholder return of 2.33%...

Ligand Pharmaceuticals recently completed a US$625,000,000 Rule 144A offering of zero-coupon, senior unsecured convertible notes due September 15, 2031, following a broader US$1,000,000,000 shelf registration for equity and related securities. A key aspect of this financing is Ligand’s plan to pair the convertible notes with call spreads and share repurchases, aiming to manage potential dilution while preserving flexibility for acquisitions such as the previously announced XOMA Royalty...

Recently, commentary on Genuine Parts highlighted that its annual sales growth, same-store sales over the past two years, and operating margin have all lagged key industry peers, raising fresh questions about its competitive performance. This combination of softer sales metrics and below-average profitability has sharpened investor focus on whether Genuine Parts can reliably generate incremental demand and sustain earnings quality in a tougher operating backdrop. We’ll now explore how...

Lamb Weston Holdings has recently faced reports of flat organic revenue, declining earnings per share, and is restructuring its European operations by closing a Netherlands production facility to improve efficiency. These moves highlight how the frozen potato producer is reworking its footprint and cost base in response to weaker demand across key markets. Next, we will examine how Lamb Weston’s European restructuring and efficiency focus may alter the existing investment narrative for the...

Teledyne MEMS recently expanded its Edmonton manufacturing operations with Government of Alberta support and was chosen by CMC Microsystems’ FABrIC initiative as the advanced MEMS manufacturing partner for Noze Inc. and Sheba Microsystems Inc. to help commercialize healthcare and automotive imaging technologies in Canada. These moves deepen Teledyne’s role in Canada’s semiconductor ecosystem, aligning its advanced MEMS capabilities with government-backed innovation and higher-value...

Jabil (JBL) is back in focus after strong third quarter results, higher full year revenue guidance of about US$35b, and a new AI focused manufacturing alliance with Adani Enterprises in India. See our latest analysis for Jabil. Despite a recent pullback, including a 1-day share price return of down 4.28% and a 7-day share price return of down 3.57%, Jabil’s momentum over longer periods remains strong. The company has a 90-day share price return of 44.90% and a 1-year total shareholder return...

Ituran Location and Control (NasdaqGS:ITRN) has drawn renewed investor attention after a recent share price pullback, with the stock down 7% over the past week and 7% over the past month. See our latest analysis for Ituran Location and Control. Despite the recent 7% pullback over the past week, Ituran Location and Control still reflects strong momentum, with the 90 day share price return at 26.66% and the 1 year total shareholder return at 71.34%. If you are weighing Ituran Location and...

Pfizer (PFE) is in focus after investors were hit with mixed oncology news, a planned CFO transition, and fresh questions around its pipeline, all set against the backdrop of patent expirations and restructuring efforts. See our latest analysis for Pfizer. At a share price of $24.29, Pfizer has seen weaker momentum in recent months, with a 30 day share price return of 7.22% and a 90 day share price return of 12.53% despite oncology updates, legal clarity around Paxlovid, and a confirmed...

BioMarin Pharmaceutical (BMRN) is back in focus after new VOXZOGO and BMN 333 data at ENDO 2026, adding fresh context to a stock that recently reacted to mixed quarterly results and updated guidance. See our latest analysis for BioMarin Pharmaceutical. Alongside the ENDO 2026 update and a recent quarter that was mixed but included higher guidance, BioMarin Pharmaceutical’s share price shows short-term momentum building, with a 7.88% seven-day share price return and a 7.68% 90-day share price...

Viking Holdings (VIK) has taken delivery of two new German-built river ships, the Viking Annar and Viking Fjolvar, aimed at expanding European itineraries on the Rhine, Main, Danube and Seine. See our latest analysis for Viking Holdings. Against this backdrop of fleet expansion, Viking Holdings has also seen strong positive momentum in its stock, with a 90 day share price return of 50.85% and a 1 year total shareholder return of 95.86%, pointing to investors reassessing both growth prospects...

Douglas Dynamics (PLOW) is back on investors’ radar after four consecutive earnings beats, with earnings per share growing faster than revenue and free cash flow giving the company more room for new initiatives and shareholder returns. See our latest analysis for Douglas Dynamics. Investors have taken notice of Douglas Dynamics’ recent earnings surprises, and the stock’s momentum reflects that, with a 30 day share price return of 20.97% feeding into a 63.35% year to date share price return...

Bio-Rad Laboratories (BIO) has drawn investor attention after recent share moves, with the stock up 0.8% on the day and 6.5% over the past week, despite a decline over the past month. See our latest analysis for Bio-Rad Laboratories. Set against a 1 year total shareholder return of 23.3% but a 5 year total shareholder return that is down 54.9%, Bio-Rad Laboratories’ recent 6.5% 7 day share price gain after a weaker 30 day share price return suggests short term momentum is improving, while...

Tango Therapeutics (TNGX) recently appointed biopharmaceutical executive Robert Azelby to its Board of Directors, as the company advances investigational PRMT5 inhibitor vopimetostat toward potential late stage development in pancreatic cancer. See our latest analysis for Tango Therapeutics. Tango Therapeutics' share price has recently shown strong momentum, with a 30 day share price return of 43.18% and a year to date share price return of 252.41%. The 1 year total shareholder return is very...

Massive rollovers from 401(k)s into IRAs are quietly reshaping where retirement dollars sit and who earns fees on them. With nearly $682 billion moving in 2023 and much more projected over the next several years, financial firms tied to retirement advice, wealth management, and IRA servicing are directly in the spotlight. This article looks at how that rollover surge, looser oversight on solicitation, and growing retiree demographics intersect, then walks through 3 stocks from our Retirement...

Analyst interest builds around ESCO Technologies after strong year-to-date run ESCO Technologies (ESE) has drawn fresh attention after a Zacks report highlighted its 75.6% year-to-date return and a favorable Rank #2 rating, with analysts pointing to improving earnings estimates as a key driver. See our latest analysis for ESCO Technologies. At a share price of $339.88, ESCO Technologies has had a strong run, with the 30 day share price return of 16.44% feeding into a year to date share price...

If you are wondering whether Centrus Energy is starting to look more interesting at current levels, the key question is how its market price compares with a grounded view of value. The stock last closed at US$165.52, with the share price down 13.5% over the past week, 9.3% over the past month and 39.3% year to date, although the three year return sits at a very large gain of about 5x. Recent coverage has focused on Centrus Energy's role in the nuclear fuel supply chain and its position in...

On June 25, 2026, Old Second Bancorp, Inc. announced that its Board authorized a new share repurchase program of up to US$61.2 million, initially running through June 30, 2027, but with the plan duration subsequently shortened to June 30, 2026. This accelerated buyback window can affect how quickly the company reduces its share count, with potential implications for earnings per share and capital deployment priorities. We will now examine how the accelerated US$61.2 million repurchase...

In late June 2026, Marvell Technology confirmed a quarterly dividend of US$0.06 per share payable on July 30, 2026, while shareholders voted against a proposal to require an independent board chair and the stock was removed from two Russell small-cap indexes. At the same time, Marvell has been tightening its focus on AI infrastructure through custom chip wins, Nvidia-backed collaborations, and acquisitions that deepen its data center connectivity and silicon capabilities. We’ll now examine...

Trinity Industries (TRN) is back in focus after entering a Third Amended and Restated Credit Agreement that replaces its prior facility, providing a $600 million unsecured revolving line of credit and an extended maturity. See our latest analysis for Trinity Industries. The new credit facility arrives as Trinity Industries trades at $36.11, with a 30-day share price return of 11.31% and year to date share price return of 33.99%, while the 1-year total shareholder return of 39.56% points to...

DocuSign (DOCU) is back in focus after the company extended its Intelligent Agreement Management platform to Perplexity Computer and Computer for Counsel, bringing AI driven contract automation directly into legal and cross functional workflows. See our latest analysis for DocuSign. Despite the new IAM integrations with Perplexity and Slackbot drawing attention to DocuSign’s AI capabilities, the stock’s 1-day share price return of 6.48% sits against a year-to-date share price decline of...

Earlier in 2026, EMCOR Group reported record quarterly revenues and operating income, beating expectations and lifting its full-year revenue guidance above prior analyst forecasts. Management also pointed to strong bookings and sustained momentum across key end markets, suggesting its growing project pipeline is translating into operational efficiencies and higher returns on capital. With EMCOR’s raised revenue guidance now on the table, we’ll examine how this operational strength influences...

Integra LifeSciences Holdings recently overhauled its commercial leadership, appointing Robert T. Davis Jr. to lead Tissue Reconstruction and Distributed Technologies, promoting Christopher Kilburn-Peterson to head the Tissue Reconstruction division, and naming Harvinder Singh to lead the Specialty Surgery division under newly appointed chief commercial officer Mike McBreen. By consolidating commercial and international operations under a single organization, Integra is placing clearer...

What the new Forest Park facility could mean for Hillman Solutions stock Hillman Solutions (HLMN) just broke ground on a 715,000 square foot multipurpose facility at the former Forest Fair Mall site in Forest Park, Ohio, consolidating several Cincinnati area operations into a single hub. This project centers on a Class A distribution space with office and support functions, and an additional 162,000 square foot expansion pad, giving Hillman Solutions room to adjust its footprint as...

What Recent Performance Says About Electronic Arts Stock Electronic Arts (EA) has drawn investor attention after a period of positive share performance, with the stock showing gains over the past week, month, and past 3 months while also posting a 1-year total return above 30%. Alongside this price action, Electronic Arts reports annual revenue of US$7.53b and net income of US$887m. These results are supported by its console, mobile, and PC free to download gaming portfolio, as well as a mix...